Exhibit 99.1
AGREEMENT OF JOINT FILING
The undersigned hereby agree that the Schedule 13G with respect to the shares of common stock, $0.00001 par value per share, of Pluristem Therapeutics Inc., dated as of February 6, 2023, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: February 6, 2023 | Regals Capital Management LP |
By: Regals Capital Holdings LLC, its general partner | |
/s/ David M. Slager | |
Name: David M. Slager | |
Title: Managing Member | |
Dated: February 6, 2023 | Regals Fund LP |
By: Regals Fund GP LLC, its general partner | |
/s/ David M. Slager | |
Name: David M. Slager | |
Title: Managing Member | |
Dated: February 6, 2023 | David M. Slager |
/s/ David M. Slager | |
Name: David M. Slager |